2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
Jasvinder A. Singh(University of Alabama at Birmingham), Daniel E. Fürst(University of California, Los Angeles), Aseem Bharat(University of Alabama at Birmingham), Jeffrey R. Curtis(University of Alabama at Birmingham), Arthur F. Kavanaugh(University of California San Diego), Joel M. Kremer(Albany Medical Center Hospital), Larry W. Moreland(University of Pittsburgh), James R. O’Dell(University of Nebraska at Omaha), Kevin Winthrop(Oregon Health & Science University), Timothy Beukelman(University of Alabama at Birmingham), S. Louis Bridges(University of Alabama at Birmingham), W. Winn Chatham(University of Alabama at Birmingham), Harold E. Paulus(University of California, Los Angeles), María E. Suarez‐Almazor(The University of Texas MD Anderson Cancer Center), Claire Bombardier(Toronto General Hospital), Maxime Dougados(Hôpital Cochin), Dinesh Khanna(University of Michigan), Charles M. King(North Mississippi Medical Center), Amye Leong(Healthy Start), Eric L. Matteson(Mayo Clinic), John T. Schousboe(University of Minnesota), Eileen Moynihan, Karen S. Kolba, Archana Jain(University of Alabama at Birmingham), Elizabeth R. Volkmann(University of California, Los Angeles), Harsh Agrawal(University of California, Los Angeles), Sangmee Bae(University of California, Los Angeles), Amy S. Mudano(University of Alabama at Birmingham), Nivedita M. Patkar(University of Alabama at Birmingham), Kenneth G. Saag(University of Alabama at Birmingham)
Cited by 1,798Open Access
Abstract
Peer Reviewed
Related Papers
No related papers found
Powered by citation graph analysis